
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6622744
[patent_doc_number] => 20100003705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'Cln101 Antibody Compositions and Methods of Use Alone and in Combination with Prostate Specific Antigen and Other Cancer Markers'
[patent_app_type] => utility
[patent_app_number] => 12/480033
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 40527
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003705.pdf
[firstpage_image] =>[orig_patent_app_number] => 12480033
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/480033 | Cln101 Antibody Compositions and Methods of Use Alone and in Combination with Prostate Specific Antigen and Other Cancer Markers | Jun 7, 2009 | Abandoned |
Array
(
[id] => 5458218
[patent_doc_number] => 20090258370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Acute Myelogenous Leukemia Biomarkers'
[patent_app_type] => utility
[patent_app_number] => 12/478930
[patent_app_country] => US
[patent_app_date] => 2009-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10919
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258370.pdf
[firstpage_image] =>[orig_patent_app_number] => 12478930
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/478930 | Acute Myelogenous Leukemia Biomarkers | Jun 4, 2009 | Abandoned |
Array
(
[id] => 7515531
[patent_doc_number] => 08039603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer'
[patent_app_type] => utility
[patent_app_number] => 12/473056
[patent_app_country] => US
[patent_app_date] => 2009-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 42
[patent_no_of_words] => 101001
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039603.pdf
[firstpage_image] =>[orig_patent_app_number] => 12473056
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/473056 | Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer | May 26, 2009 | Issued |
Array
(
[id] => 6083699
[patent_doc_number] => 20110144047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'COMBINED METHOD FOR PREDICTING THE RESPONSE TO AN ANTI-CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/993372
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19793
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144047.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993372 | COMBINED METHOD FOR PREDICTING THE RESPONSE TO AN ANTI-CANCER THERAPY | May 19, 2009 | Abandoned |
Array
(
[id] => 6118601
[patent_doc_number] => 20110076274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'MATERIALS AND METHODS RELATING TO A G-PROTEIN COUPLED RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/992312
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15767
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20110076274.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992312
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992312 | MATERIALS AND METHODS RELATING TO A G-PROTEIN COUPLED RECEPTOR | May 12, 2009 | Abandoned |
Array
(
[id] => 6202819
[patent_doc_number] => 20110065605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'METHOD FOR BIOMARKER AND DRUG-TARGET DISCOVERY FOR PROSTATE CANCER DIAGNOSIS AND TREATMENT AS WELL AS BIOMARKER ASSAYS DETERMINED THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 12/992542
[patent_app_country] => US
[patent_app_date] => 2009-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11863
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065605.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992542
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992542 | METHOD FOR BIOMARKER AND DRUG-TARGET DISCOVERY FOR PROSTATE CANCER DIAGNOSIS AND TREATMENT AS WELL AS BIOMARKER ASSAYS DETERMINED THEREWITH | May 11, 2009 | Abandoned |
Array
(
[id] => 5943439
[patent_doc_number] => 20110104059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'Membrane Associated Tumor Endothelium Markers'
[patent_app_type] => utility
[patent_app_number] => 12/436444
[patent_app_country] => US
[patent_app_date] => 2009-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17561
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104059.pdf
[firstpage_image] =>[orig_patent_app_number] => 12436444
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/436444 | Membrane Associated Tumor Endothelium Markers | May 5, 2009 | Abandoned |
Array
(
[id] => 8146468
[patent_doc_number] => 08163473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Method for using DNA repair capacity as a biomarker of breast cancer risk in women'
[patent_app_type] => utility
[patent_app_number] => 12/453250
[patent_app_country] => US
[patent_app_date] => 2009-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7618
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163473.pdf
[firstpage_image] =>[orig_patent_app_number] => 12453250
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/453250 | Method for using DNA repair capacity as a biomarker of breast cancer risk in women | May 4, 2009 | Issued |
Array
(
[id] => 5485275
[patent_doc_number] => 20090275040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'DETECTING BCL-B EXPRESSION IN CANCER AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/433481
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 31213
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275040.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433481
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433481 | Detecting Bcl-B expression in cancer and uses thereof | Apr 29, 2009 | Issued |
Array
(
[id] => 6635665
[patent_doc_number] => 20100035758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'METHOD FOR DETECTING ORAL SQUAMOUS-CELL CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 12/430639
[patent_app_country] => US
[patent_app_date] => 2009-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10485
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035758.pdf
[firstpage_image] =>[orig_patent_app_number] => 12430639
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/430639 | Method for detecting oral squamous-cell carcinoma | Apr 26, 2009 | Issued |
Array
(
[id] => 6038859
[patent_doc_number] => 20110091908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'EARLY PROSTATE CANCER ANTIGEN-2: A NOVEL SERUM SPECIFIC MARKER FOR PROSTATE CANCER DETECTION'
[patent_app_type] => utility
[patent_app_number] => 12/988502
[patent_app_country] => US
[patent_app_date] => 2009-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8323
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091908.pdf
[firstpage_image] =>[orig_patent_app_number] => 12988502
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988502 | EARLY PROSTATE CANCER ANTIGEN-2: A NOVEL SERUM SPECIFIC MARKER FOR PROSTATE CANCER DETECTION | Apr 23, 2009 | Abandoned |
Array
(
[id] => 6536147
[patent_doc_number] => 20100015639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Methods and Kits to Detect and Monitor Ovarian Cancer and Preeclampsia'
[patent_app_type] => utility
[patent_app_number] => 12/429573
[patent_app_country] => US
[patent_app_date] => 2009-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13850
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015639.pdf
[firstpage_image] =>[orig_patent_app_number] => 12429573
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429573 | Methods and kits to detect and monitor ovarian cancer and preeclampsia | Apr 23, 2009 | Issued |
Array
(
[id] => 6236358
[patent_doc_number] => 20100267658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'Trehalulose-containing composition, its preparation and use'
[patent_app_type] => utility
[patent_app_number] => 12/386187
[patent_app_country] => US
[patent_app_date] => 2009-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12039
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267658.pdf
[firstpage_image] =>[orig_patent_app_number] => 12386187
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/386187 | Trehalulose-containing composition, its preparation and use | Apr 14, 2009 | Abandoned |
Array
(
[id] => 6159691
[patent_doc_number] => 20110159017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'TRYTOPHAN CATABOLISM IN CANCER TREATMENT AND DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/936576
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19239
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159017.pdf
[firstpage_image] =>[orig_patent_app_number] => 12936576
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/936576 | TRYTOPHAN CATABOLISM IN CANCER TREATMENT AND DIAGNOSIS | Apr 9, 2009 | Abandoned |
Array
(
[id] => 6220594
[patent_doc_number] => 20100055689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'MULTIFACTORIAL METHODS FOR DETECTING LUNG DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/414555
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7415
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055689.pdf
[firstpage_image] =>[orig_patent_app_number] => 12414555
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/414555 | MULTIFACTORIAL METHODS FOR DETECTING LUNG DISORDERS | Mar 29, 2009 | Abandoned |
Array
(
[id] => 5473651
[patent_doc_number] => 20090246817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'DRY ANALYTICAL ELEMENT CAPABLE OF REDUCING INFLUENCE OF HEMOLYSIS FOR BODY FLUID COMPONENT MEASUREMENT'
[patent_app_type] => utility
[patent_app_number] => 12/410788
[patent_app_country] => US
[patent_app_date] => 2009-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4770
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246817.pdf
[firstpage_image] =>[orig_patent_app_number] => 12410788
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/410788 | Dry analytical element capable of reducing influence of hemolysis for body fluid component measurement | Mar 24, 2009 | Issued |
Array
(
[id] => 5539180
[patent_doc_number] => 20090220985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'RAPID EFFICACY ASSESSMENT METHOD FOR LUNG CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/410040
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5214
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220985.pdf
[firstpage_image] =>[orig_patent_app_number] => 12410040
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/410040 | RAPID EFFICACY ASSESSMENT METHOD FOR LUNG CANCER THERAPY | Mar 23, 2009 | Abandoned |
Array
(
[id] => 6196585
[patent_doc_number] => 20110028343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Biomarkers of Ovarian Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/935210
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6296
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028343.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935210
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935210 | Biomarkers of ovarian cancer | Mar 19, 2009 | Issued |
Array
(
[id] => 9575249
[patent_doc_number] => 08765661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Compositions containing non-polar compounds'
[patent_app_type] => utility
[patent_app_number] => 12/383241
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 63385
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12383241
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/383241 | Compositions containing non-polar compounds | Mar 19, 2009 | Issued |
Array
(
[id] => 6038858
[patent_doc_number] => 20110091907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'METHOD FOR DETECTION OF LIVER CANCER CELL USING ANTI-GLYPICAN-3 ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/736180
[patent_app_country] => US
[patent_app_date] => 2009-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14755
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091907.pdf
[firstpage_image] =>[orig_patent_app_number] => 12736180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/736180 | Method for detection of liver cancer cell using anti-glypican-3 antibody | Mar 15, 2009 | Issued |